3/A

OWNERSHIP DOCUMENT

Company: Entrada Therapeutics, Inc.
Filed: November 5, 2021
Period of Report: October 28, 2021
Accession Number: 0001104659-21-134770

View Document ↗ View on SEC.gov ↗